PPARγ actually displays antiangiogenic properties which have been proposed to disrupt the symbiosis between the tumor and the host cells in the tumor bed [46] and which impact negatively several proangiogenic factors among which VEGF, and βFGF [46, 47]. The gene discussed is PPARG; the disease is neoplasm.